Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea.
Carella
A M
AM
Hematology and ABMT Unit, Ospedale S. Martino, Genoa, Italy.
Frassoni
F
F
Pollicardo
N
N
Pungolino
E
E
Podestà
M
M
Giordano
D
D
Ferrero
R
R
Soracco
M
M
Benvenuto
F
F
Figari
O
O
D002469:Cell Separation; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D010677:Philadelphia Chromosome
D016179:Granulocyte Colony-Stimulating Factor; D006918:Hydroxyurea